LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is 4.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $26,578,000 | +7.2% | 3,567,553 | 0.0% | 1.51% | -14.1% |
Q4 2016 | $24,794,000 | -15.6% | 3,567,553 | 0.0% | 1.76% | -7.0% |
Q3 2016 | $29,360,000 | +0.4% | 3,567,553 | -1.2% | 1.90% | -6.6% |
Q2 2016 | $29,257,000 | +106.6% | 3,611,976 | +29.6% | 2.03% | +63.3% |
Q1 2016 | $14,159,000 | -38.9% | 2,787,256 | -7.1% | 1.24% | -27.5% |
Q4 2015 | $23,161,000 | -32.0% | 3,000,161 | -49.2% | 1.71% | +26.0% |
Q3 2015 | $34,046,000 | +34.5% | 5,910,912 | +114.2% | 1.36% | -10.8% |
Q2 2015 | $25,305,000 | -23.0% | 2,759,593 | +1.7% | 1.52% | -40.4% |
Q1 2015 | $32,873,000 | +29.9% | 2,714,549 | -15.6% | 2.56% | +20.4% |
Q4 2014 | $25,298,000 | +21.4% | 3,214,549 | +10.3% | 2.12% | -5.2% |
Q3 2014 | $20,839,000 | +8.1% | 2,914,549 | -3.2% | 2.24% | +18.4% |
Q2 2014 | $19,273,000 | -31.9% | 3,011,549 | +0.4% | 1.89% | -36.5% |
Q1 2014 | $28,320,000 | – | 3,000,000 | – | 2.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |